Evolent Health, Inc.·4

Feb 5, 5:39 PM ET

Stone Lydia 4

4 · Evolent Health, Inc. · Filed Feb 5, 2018

Insider Transaction Report

Form 4
Period: 2018-02-01
Stone Lydia
Principal Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2018-02-01+7,16816,755 total
Footnotes (3)
  • [F1]Represents restricted stock units granted to Ms. Stone pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 25% annually beginning February 1, 2019.
  • [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT